Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
OBIO compared with IMTX: revenue, margins and what each company keeps, and the suppliers and customers both name
OBIO
Orchestra BioMed Holdings, Inc.
Change
Mkt cap
Revenue
Revenue
IMTX
Immatics N.V.
Change
Mkt cap
Revenue
Revenue
vs
Compare
OBIO
Orchestra BioMed Holdings, Inc.
vs
IMTX
Immatics N.V.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
Supply-chain overlap
Revenue flow
OBIO: latest quarter is a loss; flow not drawable. IMTX: latest quarter not drawable.
Method
›
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
OBIO, solid
IMTX, dashed
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only OBIO
9
LGND
Ligand Pharmaceuticals Incorporated ("Ligand")
customer
MDT
Medtronic, Inc. (an affiliate of Medtronic plc) ("Medtronic")
supplier
SANM
Sanmina
supplier
ITGR
Integer Holdings Corporation ("Integer")
supplier
5 more · OBIO chain
›
Shared
0
No shared counterparties.
Only IMTX
2
BMY
Bristol-Myers Squibb
customer
MRNA
ModernaTX
customer
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR
OBIO
Orchestra BioMed Holdings, Inc.
Change
5.82
▲
+2.32%
Mkt cap
$342.0M
Revenue
$88,000
Q2 FY26
Revenue
$33M
FY25
IMTX
Immatics N.V.
Change
7.16
▲
+1.45%
Regular session
Nov 3 '26
Mkt cap
$965.3M
Revenue
—
Revenue
—
vs
Compare
Regular session
Nov 3 '26
OBIO
Orchestra BioMed Holdings, Inc.
vs
IMTX
Immatics N.V.
5.82
▲
+2.32%
Price
7.16
▲
+1.45%
$342.0M
Mkt cap
$965.3M
Q2 FY26
$88,000
Revenue
—
FY25
$33M
Revenue
—
Change
Change
OBIO
5.82
▲
+2.32%
vs
IMTX
7.16
▲
+1.45%
Regular session
Nov 3 '26